Anti-Ferritin, Light Chain (Node-Negative Breast Tumor Prognostic Marker) Monoclonal Antibody(Clone: rFTL/1388), Clone: [rFTL/1388], Mouse

Artikelnummer: ABI-36-2345
Artikelname: Anti-Ferritin, Light Chain (Node-Negative Breast Tumor Prognostic Marker) Monoclonal Antibody(Clone: rFTL/1388), Clone: [rFTL/1388], Mouse
Artikelnummer: ABI-36-2345
Hersteller Artikelnummer: 36-2345
Alternativnummer: ABI-36-2345-100UG
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC, WB
Spezies Reaktivität: Human
Immunogen: Recombinant fragment (around aa 38-165) of human FTL protein (exact sequence is proprietary)
Alternative Synonym: Ferritin L chain, Ferritin L subunit, Ferritin light chain, Ferritin light polypeptide, FTL, LFTD, NBIA3
Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
Klonalität: Monoclonal
Klon-Bezeichnung: [rFTL/1388]
NCBI: 2512
UniProt: P02792
Application Verdünnung: Western Blot (1-2ug/ml), Immunohistochemistry (Formalin-fixed) (0.1-0.2ug/ml for 30 min at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95&degC followed by cooling at RT for